Emory Cystic Fibrosis Center

Atlanta, Georgia 30322

0 studies enrolling now · 4 studies all time

What they study most

Cystic Fibrosis

Studies at this site

• Use of Formula Fortified With DHA in Infants With Cystic Fibrosis — Completed
• Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF — Completed
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation — Completed
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation — Completed